AMNEAL PHARMACEUTICALS, INC. (AMRX) Shareholders’ equity 2017–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$70.8MFY2025 · since FY2017: $0 → -$70.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.8M | +35.2% |
| FY2024 | -$109.3M | -652.4% |
| FY2023 | $19.8M | -93.4% |
| FY2022 | $298.4M | -17.2% |
| FY2021 | $360.3M | +18.8% |
| FY2020 | $303.3M | +30.7% |
| FY2019 | $232.0M | -54.0% |
| FY2018 | $504.8M | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice